Fresenius Medical Care AG (FMS) News
Follow Fresenius Medical Care AG (FMS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 14 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Focus Graphite to Attend Canada Investment Summit Hosted by Prime Minister Mark Carney; Lac Knife Featured in Investment Deal Book
Feasibility stage Lac Knife Project to be showcased to global capital with C$2.76 billion in projected life-of-mine revenue and C$236.9 million in estimated pre-production capitalOttawa, Ontario--(. - September 10, 2026)
EQUITY | Sep 10, 2026, 09:01 AM UTC
L
FMS publishes multinational real-world study on hemodiafiltration
Fresenius Medical Care announced publication of a multinational real-world evidence study linking high-volume hemodiafiltration with lower mortality risk than conventional hemodialysis.
EQUITY | Aug 27, 2026, 01:01 PM UTC
L
Focus Graphite and C4V to Evaluate Mine-to-Anode Platform Combining Lac Knife Graphite with C4V's Green Anode Technology
Focus Graphite and C4V to Evaluate Mine-to-Anode Platform Combining Lac Knife Graphite with C4V's Green Anode Technology
EQUITY | Aug 26, 2026, 09:06 AM UTC
L
Fresenius Medical Care Q2 2026 Earnings Call Transcript
Fresenius Medical Care (NYSE: FMS ) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial da
EARNINGS | Aug 04, 2026, 12:12 PM UTC
L
Powell Industries Posts Downbeat Q3 Results, Joins Clearpoint Neuro, Ichor Holdings And Other Big Stocks Moving Lower In Tuesday’s Pre-Marke
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 150 points on Tuesday. Shares of Powell Industries Inc (NASDAQ: POWL ) fell sharply in pre-market trading after the company reported
EARNINGS | Aug 04, 2026, 12:04 PM UTC
L
Fresenius Medical Care Affirms FY2026 Sales Guidance of $23.764B vs $22.940B Est
Fresenius Medical Care (NYSE: FMS ) affirms FY2026 sales outlook from $23.764 billion to $23.764 billion vs $22.940 billion estimate.
EARNINGS | Aug 04, 2026, 08:20 AM UTC
L
FMS Fresenius Medical RESULTS: Q2, Q2 REV EUR 4.861B vs. EST EUR 4.794B, Q2 Net Income EUR 218M, Q2 Ebit EUR 466M, Q2 basic EPS EUR 0.81
FMS Fresenius Medical RESULTS: Q2, Q2 REV EUR 4.861B vs. EST EUR 4.794B, Q2 Net Income EUR 218M, Q2 Ebit EUR 466M, Q2 basic EPS EUR 0.81
EARNINGS | Aug 03, 2026, 06:21 PM UTC
L
Fresenius Medical Care Appoints New Management Board Member
Fresenius Medical Care appoints Cassie McLean to Management Board
EQUITY | Aug 03, 2026, 06:20 PM UTC
H
Fresenius Medical Care Income Jumps 23%
Fresenius Medical Care income grows 23%
EQUITY | Aug 03, 2026, 06:20 PM UTC
L
Fresenius Medical Care Q2 Operating Income Beats Expectations
Fresenius Medical Care Q2 revenue up 4% to EUR 4.86B
EARNINGS | Aug 03, 2026, 05:02 PM UTC
M
Fresenius Medical Care announces BEACON-US
Fresenius Medical Care announces clinical trial results
EQUITY | Jul 29, 2026, 01:01 PM UTC
L
FMS Downgrade from Neutral to Underperform W/$19.90 PT at BNP Paribas Exane
FMS Downgrade from Neutral to Underperform W/$19.90 PT at BNP Paribas Exane
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
FMS downgraded fro Neutral to Underperform @ BNP
FMS downgraded fro Neutral to Underperform @ BNP
EQUITY | Jul 28, 2026, 11:45 AM UTC
L
FMS new Market Perform @ Bernstein
FMS new Market Perform @ Bernstein
EQUITY | Jul 16, 2026, 11:29 AM UTC